Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Peptide Modification Diminishes HLA Class II-restricted CD4+ T Cell Recognition of Prostate Cancer Cells.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Peptide Modification Diminishes HLA Class II-restricted CD4+ T Cell Recognition of Prostate Cancer Cells.
Peptide Modification Diminishes HLA Class II-restricted CD4+ T Cell Recognition of Prostate Cancer Cells. Int J Mol Sci. 2022 Dec 03; 23(23).
View in:
PubMed
authors with profiles
Narendra L. Banik
Jennifer Rutherford Bethard
Azizul Haque